Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct 31;49(5):735-41.
doi: 10.3349/ymj.2008.49.5.735.

The effect of high dose melatonin on cardiac ischemia- reperfusion Injury

Affiliations

The effect of high dose melatonin on cardiac ischemia- reperfusion Injury

Hakan Ceyran et al. Yonsei Med J. .

Abstract

Purpose: Melatonin, the most potent scavenger of toxic free radicals, has been found to be effective in protecting against pathological states due to the release of reactive oxygen species. This study was performed to establish the effect of high dose melatonin on protection against ischemia- reperfusion (I/R) injury in rat hearts.

Materials and methods: Forty male Sprague-Dawley rats were used in this study. They were separated into four groups of ten rats each. A left coronary artery occlusion was induced in the rats by ligating the artery for 20 minutes and then releasing the ligation (reperfusion) afterwards. The control group was Group A. Group B was subjected to myocardial ischemia-reperfusion without any treatment, while Group C underwent myocardial ischemia-reperfusion with a melatonin treatment before the ischemia. Group D was subjected to myocardial ischemia-reperfusion with a melatonin treatment before the reperfusion. After 20 minutes of reperfusion, blood samples were obtained from each group for biochemical studies, and the animals were sacrificed for histological and, immunohistochemical examinations of the myocardial tissue.

Results: We found that the cardiac troponin T(cTn-T) levels were significantly increased in Group B when all groups were compared. In the Group C rats treated with melatonin, the cTn-T values were significantly lower than those in Groups B and D. In addition, malondialdehyde (MDA) and antioxidant enzymes including, superoxide dismutase (SOD) and myeloperoxidase (MPO) were lower than those in Group B in the melatonin treated groups. The differences were statistically significant (p < 0.05). Histopathologic and immunohistopathologic studies also supported the effectiveness of melatonin.

Conclusion: Our study suggests that high dose melatonin, appears to offer protection against cardiac ischemia-reperfusion injuries in rats by scavenging the free radicals and could have a potential clinical use in the management of myocardial ischemia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Melatonin treatment was associated with decrease Fas expression while Bcl-2 expression were significantly higher in ischemic-reperfused hearts in rats Groups C and D.
Fig. 2
Fig. 2
Strong immunoreactivity with Bcl-2 in myofibrilles in Group C (IHK × 200).
Fig. 3
Fig. 3
Severe edema among myofibrilles in non-treated melatonin Group B (H & E × 200).
Fig. 4
Fig. 4
Minimal edema among myofibrilles in treated melatonin Group C (H & E × 100).

Similar articles

Cited by

References

    1. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res. 1992;26:101–108. - PubMed
    1. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res. 1998;82:166–174. - PubMed
    1. Kaneko S, Okumura K, Numaguchi Y, Matsui H, Murase K, Mokuno S, et al. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci. 2000;67:101–112. - PubMed
    1. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J. 1993;1:57–60.
    1. Reiter RJ, Poeggeler B, Tan DX, Chen LD, Manchester LC, Cuerrero JM. Antioxidant capacity of melatonin: a novel action not requiring receptor. Neuro Endocrinol Lett. 1993;15:103–116.